Background The optimal radiotherapy regimen in elderly patients with glioblastoma treated
by chemoradiation needs to be addressed. We provide the results of a comparison between …

To determine the outcome of elderly patients with glioblastoma managed with
hypofractionated [40 Gray (Gy)] or long-course (60 Gy) radiation therapy (RT). Patients …

We hypothesized elderly patients with good Karnofsky Performance Status (KPS) treated
with standard dose or dose-escalated radiation therapy (SDRT/DERT) and concurrent …

Conclusions: RT±TMZ seems to be a well-tolerated treatment in patients≥ 70 years with
GBM. Even though no superiority was found between conventional or hypofractionated RT …

Purpose To evaluate 2 specific radiation schedules, each combined with temozolomide
(TMZ), assessing their efficacy and safety in patients aged≥ 65 years with newly diagnosed …

Objectives The optimal treatment for elderly patients (age> 70 years) with glioblastoma
(GBM) remains controversial. We conducted a prospective trial in 43 consecutive elderly …

Objectives: Age is an unfavorable prognostic factor in glioblastoma multiforme (GBM). To
assess the possibility and the advantage of radiotherapy (RT) plus concomitant/sequential …

Objective: The objective of this article was to evaluate therapeutic outcomes of elderly
patients with glioblastoma multiforme (GBM) treated by surgery followed by combined …

Background The optimization of the management for elderly glioblastoma patients is crucial
given the demographics of aging in many countries. We report the outcomes for a “real-life” …

Introduction Elderly patients have glioblastomas (GBM) that are aggressive and poorly
responsive to treatment. They are also prone to the side effects of treatment of GBM …